Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.[2]
This antiinfective drug article is a stub. You can help Wikipedia by expanding it.
This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.